or Try an Advanced Search...

    Technical Analysis for DYN - Dyne Therapeutics, Inc.

    Grade Last Price % Change Price Change
    D 33.26 -0.63% -0.21
    DYN closed down 5.02 percent on Monday, October 21, 2024, on 57 percent of normal volume.
    Earnings due: Oct 28
    *** please verify all earnings dates ***
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Down Down
    Historical DYN trend table...
    Date Alert Name Type % Chg
    Fell Below 20 DMA Bearish -0.63%
    180 Bearish Setup Bearish Swing Setup -0.63%
    Pocket Pivot Bullish Swing Setup -5.62%
    NR7 Range Contraction -5.62%
    Stochastic Reached Overbought Strength -5.62%
    Weak + Overbought Other -5.62%
    Weak, Overbought and Reversal Signs Reversal -5.62%
    Overbought Stochastic Strength -5.62%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -4.23%
    Inside Day Range Contraction -4.23%
    Older End-of-Day Signals for DYN ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 11 minutes ago
    Bearish 180 Entry about 4 hours ago
    Fell Below Previous Day's Low about 4 hours ago
    Down 2 % about 4 hours ago
    Down 1% about 4 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    DYN Chart by TradingView
    Basic chart:

    Profile

    Dyne Therapeutics is building a leading muscle disease company focused on advancing innovative life-transforming therapeutics for patients with genetically driven diseases. The Company utilizes its proprietary FORCE™ platform to overcome the current limitations of muscle tissue delivery with modern oligonucleotide therapeutic candidates. Dyne is developing a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1 (DM1), Duchenne muscular dystrophy (DMD) and facioscapulohumeral muscular dystrophy (FSHD).
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Disease Medical Genetics Dystrophy Muscular Dystrophy Duchenne Muscular Dystrophy Oligonucleotide Duchenne Genetic Genealogy Myotonic Dystrophy Dystrophin Facioscapulohumeral Muscular Dystrophy Muscle Disease Muscle Diseases

    Is DYN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 21 Top small-cap stock picks from Morgan Stanley following the group's upgrade to neutral
    Oct 9 Dyne Therapeutics Presents Data at World Muscle Society Congress Highlighting Promise of FORCE™ Platform to Address Underlying Causes of Neuromuscular Diseases
    Oct 7 Dyne Therapeutics, Inc. (DYN): A Hot Stock to Buy Now
    Sep 23 Dyne Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines Conference
    Sep 6 CEO, President & Director of Dyne Therapeutics John Cox Buys 640% More Shares
    Sep 5 Biotech Stock Roundup: NVAX Vaccine Approval, ALNY, ATHA Stock Dive on Updates & More
    Sep 4 Dyne Therapeutics: Management Merry-Go-Round, Shaky Data Rock Wall Street
    Sep 4 Dyne Reports Mixed Data From DMD Study, Key Executives Step Down
    Sep 4 High-dose Spinraza meets study goal; Top Dyne executives exit
    Sep 3 Dyne stock tumbles 31% amid drug updates, management changes
    See more DYN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 47.45
    52 Week Low 6.4
    Average Volume 1,250,885
    200-Day Moving Average 31.07
    50-Day Moving Average 37.28
    20-Day Moving Average 33.89
    10-Day Moving Average 33.71
    Average True Range 1.74
    RSI (14) 45.65
    ADX 26.74
    +DI 19.60
    -DI 26.94
    Chandelier Exit (Long, 3 ATRs) 31.81
    Chandelier Exit (Short, 3 ATRs) 36.47
    Upper Bollinger Bands 36.24
    Lower Bollinger Band 31.55
    Percent B (%b) 0.41
    BandWidth 13.82
    MACD Line -0.59
    MACD Signal Line -0.94
    MACD Histogram 0.3488
    Fundamentals Value
    Market Cap 2.71 Billion
    Num Shares 81.1 Million
    EPS -3.59
    Price-to-Earnings (P/E) Ratio -9.32
    Price-to-Sales 0.00
    Price-to-Book 12.82
    PEG Ratio 0.19
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 35.82
    Resistance 3 (R3) 36.07 35.53 35.43
    Resistance 2 (R2) 35.53 34.94 35.41 35.30
    Resistance 1 (R1) 34.50 34.57 34.24 34.25 35.17
    Pivot Point 33.97 33.97 33.84 33.84 33.97
    Support 1 (S1) 32.94 33.37 32.67 32.69 31.77
    Support 2 (S2) 32.40 33.00 32.28 31.64
    Support 3 (S3) 31.37 32.40 31.51
    Support 4 (S4) 31.12